H19 lncRNA mediates 17β-estradiol-induced cell proliferation in MCF-7 breast cancer cells

Oncology Reports

Volumn 33, Issue 6, 2015, Pages 3045-3052

  Sun, Hong ^a,b   Wang, Guo ^a   Peng, Yan ^a   Zeng, Ying ^a   Zhu, Qiong Ni ^a   Li, Tai Lin ^a   Cai, Jia Qin ^b   Zhou, Hong Hao ^a   Zhu, Yuan Shan ^a  

^a Central South University   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Cell proliferation; Estrogen; Estrogen receptor ; H19 lncRNA; MCF 7 cells

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; H19 LONG UNTRANSLATED RNA; LONG UNTRANSLATED RNA; UNCLASSIFIED DRUG; H19 LONG NON-CODING RNA;

ARTICLE; BREAST CANCER; CANCER TISSUE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC SCREENING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MCF 7 CELL LINE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA INTERFERENCE; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY;

BREAST NEOPLASMS; CELL PROLIFERATION; CELL SURVIVAL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; RNA, LONG NONCODING;

EID: 84928890226     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.3899     Document Type: Article

References (29)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Harvey JM, Clark GM, Osborne CK and Allred DC: Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17: 1474-1481, 1999.
3. Stender JD, Frasor J, Komm B, Chang KC, Kraus WL and Katzenellenbogen BS: Estrogen-regulated gene networks in human breast cancer cells: Involvement of E2F1 in the regulation of cell proliferation. Mol Endocrinol 21: 2112-2123, 2007.
4. Osborne CK: Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat 51: 227-238, 1998.
5. Katzenellenbogen BS, Montano MM, Ediger TR, et al: Estrogen receptors: Selective ligands, partners, and distinctive pharmacology. Recent Prog Horm Res 55: 163-195, 2000.
6. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR and Katzenellenbogen BS: Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: Insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144: 4562-4574, 2003.
7. Stossi F, Barnett DH, Frasor J, Komm B, Lyttle CR and Katzenellenbogen BS: Transcriptional profiling of estrogenregulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: Distinct and common target genes for these receptors. Endocrinology 145: 3473-3486, 2004.
8. Li CH and Chen Y: Targeting long non-coding RNAs in cancers: Progress and prospects. Int J Biochem Cell Biol 45: 1895-1910, 2013.
9. Pauli A, Rinn JL and Schier AF: Non-coding RNAs as regulators of embryogenesis. Nat Rev Genet 12: 136-149, 2011.
10. Ponting CP, Oliver PL and Reik W: Evolution and functions of long noncoding RNAs. Cell 136: 629-641, 2009.
11. Wapinski O and Chang HY: Long noncoding RNAs and human disease. Trends Cell Biol 21: 354-361, 2011.
12. Prensner JR and Chinnaiyan AM: The emergence of lncRNAs in cancer biology. Cancer Discov 1: 391-407, 2011.
13. Bartolomei MS, Zemel S and Tilghman SM: Parental imprinting of the mouse H19 gene. Nature 351: 153-155, 1991.
14. Ariel I, de Groot N and Hochberg A: Imprinted H19 gene expression in embryogenesis and human cancer: The oncofetal connection. Am J Med Genet 91: 46-50, 2000.
15. Glaser T, Housman D, Lewis WH, Gerhard D and Jones C: A fine-structure deletion map of human chromosome 11p: Analysis of J1 series hybrids. Somat Cell Mol Genet 15: 477-501, 1989.
16. Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, Hochberg A and Galun E: The H19 non-coding RNA is essential for human tumor growth. PLoS One 2: e845, 2007.
17. Luo M, Li Z, Wang W, Zeng Y, Liu Z and Qiu J: Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett 333: 213-221, 2013.
18. Adriaenssens E, Dumont L, Lottin S, Bolle D, Leprêtre A, Delobelle A, Bouali F, Dugimont T, Coll J and Curgy JJ: H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression. Am J Pathol 153: 1597-1607, 1998.
19. Lottin S, Adriaenssens E, Dupressoir T, Berteaux N, Montpellier C, Coll J, Dugimont T and Curgy JJ: Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis 23: 1885-1895, 2002.
20. Berteaux N, Lottin S, Monté D, Pinte S, Quatannens B, Coll J, Hondermarck H, Curgy JJ, Dugimont T and Adriaenssens E: H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem 280: 29625-29636, 2005.
21. Adriaenssens E, Lottin S, Dugimont T, Fauquette W, Coll J, Dupouy JP, Boilly B and Curgy JJ: Steroid hormones modulate H19 gene expression in both mammary gland and uterus. Oncogene 18: 4460-4473, 1999.
22. Tsang WP and Kwok TT: Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells. Oncogene 26: 4877-4881, 2007.
23. Tan C, Cai LQ, Wu W, Qiao Y, Imperato-McGinley J, Chen GQ and Zhu YS: NSC606985, a novel camptothecin analog, induces apoptosis and growth arrest in prostate tumor cells. Cancer Chemother Pharmacol 63: 303-312, 2009.
24. Brannan CI, Dees EC, Ingram RS and Tilghman SM: The product of the H19 gene may function as an RNA. Mol Cell Biol 10: 28-36, 1990.
25. Gabory A, Jammes H and Dandolo L: The H19 locus: Role of an imprinted non-coding RNA in growth and development. BioEssays 32: 473-480, 2010.
26. Hao Y, Crenshaw T, Moulton T, Newcomb E and Tycko B: Tumour-suppressor activity of H19 RNA. Nature 365: 764-767, 1993.
27. Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL, Tsao MS and Penn LZ: The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res 66: 5330-5337, 2006.
28. Doucrasy S, Coll J, Barrois M, Joubel A, Prost S, Dozier C, Stehelin D and Riou G: Expression of the human fetal bac h19 gene in invasive cancers. Int J Oncol 2: 753-758, 1993.
29. Dugimont T, Curgy JJ, Wernert N, Delobelle A, Raes MB, Joubel A, Stehelin D and Coll J: The H19 gene is expressed within both epithelial and stromal components of human invasive adenocarcinomas. Biol Cell 85: 117-124, 1995.